JP2010535829A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535829A5
JP2010535829A5 JP2010520498A JP2010520498A JP2010535829A5 JP 2010535829 A5 JP2010535829 A5 JP 2010535829A5 JP 2010520498 A JP2010520498 A JP 2010520498A JP 2010520498 A JP2010520498 A JP 2010520498A JP 2010535829 A5 JP2010535829 A5 JP 2010535829A5
Authority
JP
Japan
Prior art keywords
ethylsulfonyl
naphthalen
polymorphs
oxazole
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010520498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535829A (ja
Filing date
Publication date
Priority claimed from GBGB0715937.9A external-priority patent/GB0715937D0/en
Application filed filed Critical
Publication of JP2010535829A publication Critical patent/JP2010535829A/ja
Publication of JP2010535829A5 publication Critical patent/JP2010535829A5/ja
Pending legal-status Critical Current

Links

JP2010520498A 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用の化合物の多形体 Pending JP2010535829A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0715937.9A GB0715937D0 (en) 2007-08-15 2007-08-15 Method of treatment og duchenne muscular dystrophy
PCT/EP2008/006718 WO2009021748A2 (en) 2007-08-15 2008-08-14 Polymorphs of a compound for the treatment of duchenne muscular dystrophy

Publications (2)

Publication Number Publication Date
JP2010535829A JP2010535829A (ja) 2010-11-25
JP2010535829A5 true JP2010535829A5 (OSRAM) 2011-09-29

Family

ID=38566447

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010520498A Pending JP2010535829A (ja) 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用の化合物の多形体
JP2010520499A Pending JP2010535830A (ja) 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用化合物の製造

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010520499A Pending JP2010535830A (ja) 2007-08-15 2008-08-14 デュシェンヌ型筋ジストロフィーの治療用化合物の製造

Country Status (17)

Country Link
US (2) US8138351B2 (OSRAM)
EP (2) EP2176246A2 (OSRAM)
JP (2) JP2010535829A (OSRAM)
KR (1) KR20100075777A (OSRAM)
CN (2) CN101896475A (OSRAM)
AR (1) AR068810A1 (OSRAM)
AU (2) AU2008286324A1 (OSRAM)
BR (2) BRPI0811548A2 (OSRAM)
CA (2) CA2685939A1 (OSRAM)
CL (1) CL2008002391A1 (OSRAM)
GB (1) GB0715937D0 (OSRAM)
IL (1) IL201908A0 (OSRAM)
MX (2) MX2009011967A (OSRAM)
PE (1) PE20090604A1 (OSRAM)
RU (1) RU2009141831A (OSRAM)
TW (1) TW200911767A (OSRAM)
WO (2) WO2009021748A2 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1986633T3 (da) * 2006-02-10 2014-11-03 Summit Corp Plc Behandling af duchennes muskeldystrofi
GB201208178D0 (en) 2012-05-10 2012-06-20 Summit Corp Plc Pharmaceutical composition for the treatment of duchenne muscular dystrophy
GB201412010D0 (en) 2014-07-04 2014-08-20 Summit Corp Plc Treatment of hypertransaminasemia
MX2018012018A (es) * 2016-03-30 2019-07-04 Summit Oxford Ltd Composicion para el tratamiento de la distrofía muscular de duchenne.
WO2017175842A1 (ja) * 2016-04-07 2017-10-12 国立大学法人京都大学 スプライシングの改変に関する化合物及び医薬組成物
KR102019048B1 (ko) 2017-02-06 2019-09-09 가톨릭대학교 산학협력단 MG53과 Orai1의 결합을 이용한 근육긴장저하 치료제 스크리닝 방법
KR101886788B1 (ko) 2017-02-07 2018-08-09 가톨릭대학교 산학협력단 MG53과 Orai1의 결합을 이용한 뒤시엔느 골격근 위축증 치료제 스크리닝 방법
EP4403171A3 (en) 2017-06-19 2024-09-11 University of Maryland, Baltimore Microtubule polymerization inhibitor prodrugs and methods of using the same

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993659A (en) * 1971-08-10 1976-11-23 Ciba-Geigy Corporation Bis-benzoxazolyl-naphthalenes as optical brighteners
CH617809GA3 (OSRAM) * 1975-10-10 1980-06-30
US4110246A (en) * 1976-05-13 1978-08-29 Hoechst Aktiengesellschaft Mixture of benzoxazole derivatives
DE3027479A1 (de) * 1980-07-19 1982-03-04 Hoechst Ag, 6000 Frankfurt Mischungen von optischen aufhellern und deren verwendung
JPS615071A (ja) * 1984-06-15 1986-01-10 Fuji Photo Film Co Ltd ベンゾオキサゾ−ル誘導体
DE3617451A1 (de) * 1986-05-23 1987-11-26 Hoechst Ag Sulfonat- oder sulfonamidgruppen-haltige bis-benzoxazolylnaphthaline, verfahren zu deren herstellung und deren verwendung
DE3819051A1 (de) * 1988-06-04 1989-12-07 Agfa Gevaert Ag Farbfotografisches aufzeichnungsmaterial
EP0527704B1 (de) * 1991-08-08 1996-08-28 Ciba-Geigy Ag Farbstoffe, Verfahren zu deren Herstellung und deren Verwendung
EP0669323B2 (de) * 1994-02-24 2004-04-07 Haarmann & Reimer Gmbh Kosmetische und dermatologische zubereitungen, enthaltend phenylen-1,4-bisbenzimidiazolesulfonsäuren
US6004719A (en) * 1994-04-25 1999-12-21 Polaroid Corporation Imaging medium and process for producing an image
EP0767809B1 (en) * 1994-06-30 2004-01-21 Minnesota Mining And Manufacturing Company Cure-indicating molding and coating composition
US5596025A (en) * 1994-06-30 1997-01-21 Minnesota Mining And Manufacturing Company Dental impression material with cure-indicating dye
US6222044B1 (en) * 1995-03-20 2001-04-24 The Dow Chemical Company Process for making 2-aryl benz (ox, thi, imid) azoles and 2-aminoaryl aminobenz (ox, thi, imid) azoles
US5567843A (en) * 1995-03-20 1996-10-22 The Dow Chemical Company Process for making 2-aryl benz (ox, thi, imid)azoles and 2-aminoaryl aminobenz(ox, thi, imid)azoles
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US5645948A (en) * 1996-08-20 1997-07-08 Eastman Kodak Company Blue organic electroluminescent devices
US5914213A (en) * 1996-11-27 1999-06-22 Polaroid Corporation Process and composition for generation of acid
US6110638A (en) * 1996-11-27 2000-08-29 Polaroid Corporation Process and composition for generation of acid
US6177572B1 (en) * 1997-08-20 2001-01-23 Sepracor, Inc. Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
US6312822B1 (en) * 1998-05-28 2001-11-06 Eastman Chem Co Dispersion aids for optical brighteners in polyolefins
GB9815880D0 (en) * 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US6436558B1 (en) * 1998-08-07 2002-08-20 Fuji Photo Film Co., Ltd. Organic electroluminescence element
FR2789581B1 (fr) * 1999-02-12 2001-05-04 Oreal Compositions photoprotectrices contenant un derive de benzotriazole, un derive de bis-resorcinyl triazine et un compose a groupements benzoazolyle ou benzodiazolyle
FR2789582B1 (fr) * 1999-02-12 2001-05-04 Oreal Compositions photoprotectrices contenant un derive de bis-resorcinyl triazine et un compose a groupements benzoazolyle ou benzodiazolyle
CA2373137A1 (en) * 1999-05-07 2000-11-16 Basf Aktiengesellschaft Benzohetero cyclylcyclo hexenones and their use as herbicides
AU4562000A (en) * 1999-05-07 2000-11-21 Basf Aktiengesellschaft 4-(3',4'-heterocyclyl benzoyl) pyrazoles as herbicidal agents
FR2794645B1 (fr) * 1999-06-08 2001-08-10 Oreal Compositions photoprotectrices contenant un compose hydrocarbone bis-hydroxyphenylbenzotriazole et un compose a groupements benzoazolyle ou benzodiazolyle
KR20020032618A (ko) * 1999-09-24 2002-05-03 우에노 도시오 히드록삼산 유도체 화합물, 그 제조 방법 및 그 화합물을유효 성분으로 하는 의약
US6565987B2 (en) * 1999-11-12 2003-05-20 Eastman Chemical Company Non-exuding optically brightened polyolefin blends
US6716413B1 (en) * 2000-10-16 2004-04-06 Mallinckrodt, Inc. Indole compounds as tissue-specific exogenous optical agents
KR100846526B1 (ko) * 2000-11-30 2008-07-15 캐논 가부시끼가이샤 발광 소자 및 표시 장치
US20050261298A1 (en) * 2002-01-18 2005-11-24 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
US20050113283A1 (en) * 2002-01-18 2005-05-26 David Solow-Cordero Methods of treating conditions associated with an EDG-4 receptor
WO2003075921A2 (en) * 2002-03-05 2003-09-18 Transtech Pharma, Inc. Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
WO2004035522A1 (ja) * 2002-08-30 2004-04-29 Bf Research Institute, Inc. プリオン蛋白蓄積性疾患の診断プローブおよび治療薬ならびにプリオン蛋白の染色剤
JP2007500219A (ja) * 2003-05-16 2007-01-11 アンビット バイオサイエンシス コーポレーション 複素環化合物およびその使用法
WO2005000295A1 (en) * 2003-05-20 2005-01-06 Transtech Pharma, Inc. Rage antagonists as agents to reverse amyloidosis and diseases associated therewith
WO2005023761A2 (en) * 2003-09-11 2005-03-17 Kemia, Inc. Cytokine inhibitors
DE602004021120D1 (de) * 2003-09-22 2009-06-25 Agfa Graphics Nv Photopolymerisierbare zusammensetzung.
US7097888B2 (en) * 2003-12-15 2006-08-29 Eastman Kodak Company Aligned liquid crystal layer containing azolium salts and process for increasing the tilt
US7592373B2 (en) * 2003-12-23 2009-09-22 Boehringer Ingelheim International Gmbh Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
EP1720828A2 (en) * 2004-02-06 2006-11-15 Insight Biopharmaceuticals Ltd Heparanase inhibitors and uses thereof
MY144903A (en) * 2004-06-17 2011-11-30 Novartis Ag Pyrrolopyridine derivatives and their use as crth2 antagonists
CN101006159B (zh) * 2004-08-19 2011-11-09 Lg化学株式会社 包括缓冲层的有机发光器件及其制备方法
US7723340B2 (en) * 2005-01-13 2010-05-25 Signal Pharmaceuticals, Llc Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
AU2006223070B2 (en) * 2005-03-14 2012-02-09 High Point Pharmaceuticals, Llc Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
JP2007086165A (ja) * 2005-09-20 2007-04-05 Fujifilm Corp 感光性組成物、これを用いた平版印刷版原版及び画像記録方法
ES2455166T3 (es) * 2005-12-02 2014-04-14 Sachem, Inc. Procedimiento de cromatografía de desplazamiento de intercambio aniónico
KR101213485B1 (ko) * 2006-01-27 2012-12-18 삼성디스플레이 주식회사 유기 금속 착물 및 이를 이용한 유기 전계 발광 소자
KR101213486B1 (ko) * 2006-02-02 2012-12-20 삼성디스플레이 주식회사 유기 금속 착물 및 이를 이용한 유기 전계 발광 소자
DK1986633T3 (da) * 2006-02-10 2014-11-03 Summit Corp Plc Behandling af duchennes muskeldystrofi
KR101325062B1 (ko) * 2006-05-19 2013-11-05 삼성디스플레이 주식회사 발광 이종 핵 구리-이리듐 착체 및 이를 이용한 유기 전계발광 소자

Similar Documents

Publication Publication Date Title
JP2010535829A5 (OSRAM)
JP2009541403A5 (OSRAM)
JP2010501534A5 (OSRAM)
JP2010507682A5 (OSRAM)
JP2009149903A5 (OSRAM)
JP2011508438A5 (OSRAM)
JP2009535462A5 (OSRAM)
JP2010536766A5 (OSRAM)
JP2009524695A5 (OSRAM)
JP2016504351A5 (OSRAM)
JP2012522259A5 (OSRAM)
JP2007269812A5 (OSRAM)
WO2007087416A3 (en) Methods of increasing oral bioavailability of tetracyclines
JP2011523810A5 (OSRAM)
JP2010504301A5 (OSRAM)
JP2014102408A5 (OSRAM)
JP2009544651A5 (OSRAM)
JP2012042477A5 (OSRAM)
EP2146979A4 (en) NOVEL PROCESS FOR THE MANUFACTURE OF 2-HYDROXY-3- [5- (MORPHOLIN-4-YLMETHYL) PYRIDIN-2-YL] 1H-INDOLE-5-CARBONITRILE 701
JP2013521273A5 (OSRAM)
JP2008266364A5 (OSRAM)
JP2012507479A5 (OSRAM)
JP2010514800A5 (OSRAM)
JP2006506499A5 (OSRAM)
WO2009021748A3 (en) Polymorphs of a compound for the treatment of duchenne muscular dystrophy